Marex Group plc, a financial services platform provider company, provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and financial futures and options; liquidity and execution services for financial securities through trading desks that cover products, including foreign exchange, equities, fixed income, and others. It also operates as an agent to trade in OTC energy products using knowledge of the energy sector and relationships with clients for oil, power and gas, and shipping and freight products; and provides market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across commodity markets comprising agriculture, metals, energy, and currency markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates. Additionally, it offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. The company operates in the United Kingdom, the United States, and internationally. Marex Group plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Marex Group plc

Analysts have been eager to weigh in on the Financial sector with new ratings on Metlife (MET), Marex Group plc (MRX) and Allstate (ALL). Metlife (...

Analysts Offer Insights on Financial Companies: Metlife (MET), Marex Group plc (MRX) and Allstate (ALL)

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Nu Holdings (NU) and Marex Group plc (MRX) with bulli...

Analysts Offer Insights on Financial Companies: Nu Holdings (NU) and Marex Group plc (MRX)

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Marex Group plc (MRX) and Bank Of Montreal (BMO). M...

Analysts Offer Insights on Financial Companies: Marex Group plc (MRX) and Bank Of Montreal (BMO)

An announcement from Marex Group plc ( ($MRX) ) is now available. On March 26, 2026, Marex Group forecast a strong first quarter, guiding revenue b...

Marex Group Plans Bermuda Redomiciliation as It Forecasts Record Q1 2026 Results

Marex Group plc ( ($MRX) ) just unveiled an announcement. On March 25, 2026, Marex Group plc released its 2025 Group Annual Report and Accounts, de...

Marex Group Posts Record 2025 Results and Details Growth Strategy in Newly Published Annual Report

Barclays analyst Benjamin Budish maintained a Buy rating on Marex Group plc today and set a price target of $50.00. According to TipRanks, Budish i...

Barclays Sticks to Their Buy Rating for Marex Group plc (MRX)

Barclays analyst Glen Santangelo maintained a Buy rating on Amneal Pharmaceuticals today and set a price target of $15.00. Santangelo covers the He...

Barclays Sticks to Their Buy Rating for Amneal Pharmaceuticals (AMRX)

Analysts have been eager to weigh in on the Financial sector with new ratings on Regions Financial (RF – Research Report) and Marex Group plc (MRX ...

Analysts Offer Insights on Financial Companies: Regions Financial (RF) and Marex Group plc (MRX)

In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Immuneering, with a price target of $12.00. Suvanna...

Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Immuneering (IMRX – Research Report) and RxSight (RXST – Research...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MRX	$48.60	+3.47%	1.47M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MRX	$48.60	+3.5%	1.47M
3
4
5
6

MRX

MRX

No Data Available

Get Marex Group plc Data in Excel

Get Marex Group plc Data in Excel